Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - ArriVent BioPharma, Inc. Common Stock | StockGist | StockGist

Companies
AVBP
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings AVBPSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

ArriVent BioPharma, Inc. Common Stock

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001868279

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

ArriVent BioPharma, Inc.

Person Type

IA

CUSIP: 04272N102

Amendment History

4 filings

SCHEDULE 13G
Original
Jan 21, 20260002012383-26-000643
SCHEDULE 13G/A
Amendment 1
Jan 30, 20260000102909-26-000090
SCHEDULE 13G/A
Amendment 2
Feb 17, 20260000902664-26-001013
SCHEDULE 13G/A
Amendment 3
Latest
Viewing
Feb 17, 20260002058093-26-000004

Recent Filings

ArriVent BioPharma, Inc. Common Stock4 weeks ago

ArriVent BioPharma, Inc. Common Stock4 weeks ago

ArriVent BioPharma, Inc. Common Stock4 weeks ago

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice